Literature DB >> 10714765

A role for E2F1 in the induction of apoptosis during thymic negative selection.

I García1, M Murga, A Vicario, S J Field, A M Zubiaga.   

Abstract

Thymic negative selection is the process in which maturing thymocytes that express T-cell receptors recognizing self are eliminated by apoptotic cell death. The molecular mechanism by which this occurs is poorly understood. Notably, genes involved in cell death, even thymocyte death, such as Fas, Fas-ligand, p53, caspase-1, caspase-3, and caspase-9, and Bcl-2 have been found to not be required for normal thymic negative selection. We have demonstrated previously that E2F1-deficient mice have a defect in thymocyte apoptosis. Here we show that E2F1 is required for normal thymic negative selection. Furthermore, we observed an E2F1-dependent increase of p53 protein levels during the process of thymic clonal deletion, which suggests that E2F1 regulates activation-induced apoptosis of self-reactive thymocytes by a p53-dependent mechanism. In contrast, other apoptotic pathways operating on developing thymocytes, such as glucocorticoid-induced cell death, are not mediated by E2F1. The T lymphocytes that escape thymic negative selection migrate to the peripheral immune system but do not appear to be autoreactive, indicating that there may exist E2F1-independent mechanisms of peripheral tolerance, which protect mice from developing an autoimmune response. We expect that E2F1-deficient mice will provide a useful tool for understanding the molecular mechanism of and the immunological importance of thymic negative selection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10714765

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  11 in total

1.  E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis.

Authors:  J W Zhu; S J Field; L Gore; M Thompson; H Yang; Y Fujiwara; R D Cardiff; M Greenberg; S H Orkin; J DeGregori
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice.

Authors:  Feng X Li; Jing W Zhu; Christopher J Hogan; James DeGregori
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

3.  Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo.

Authors:  Jennifer E Cloud; Catherine Rogers; Tammi L Reza; Ulrike Ziebold; James R Stone; Michael H Picard; Alicia M Caron; Roderick T Bronson; Jacqueline A Lees
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 4.  Absent in Melanoma 2 proteins in SLE.

Authors:  Divaker Choubey; Ravichandran Panchanathan
Journal:  Clin Immunol       Date:  2017-01-03       Impact factor: 3.969

5.  E2F1: a potential therapeutic target for systematic lupus erythematosus.

Authors:  Xin-Yu Fang; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2013-09-27       Impact factor: 2.631

6.  Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice.

Authors:  Ainhoa Iglesias; Matilde Murga; Usua Laresgoiti; Anouchka Skoudy; Irantzu Bernales; Asier Fullaondo; Bernardino Moreno; José Lloreta; Seth J Field; Francisco X Real; Ana M Zubiaga
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

7.  E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas.

Authors:  Ulrike Ziebold; Eunice Y Lee; Roderick T Bronson; Jacqueline A Lees
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

8.  Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupus-prone mice.

Authors:  Ravichandran Panchanathan; Hong Xin; Divaker Choubey
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

9.  Dual downregulation of microRNA 17-5p and E2F1 transcriptional factor in pediatric systemic lupus erythematosus patients.

Authors:  Heba Ragaee Abdelhakam Aboelenein; Samia Salah; Yasmine Adel Lashine; Ahmed Ihab Abdelaziz
Journal:  Rheumatol Int       Date:  2012-11-06       Impact factor: 2.631

10.  Impaired pancreatic growth, beta cell mass, and beta cell function in E2F1 (-/- )mice.

Authors:  Lluis Fajas; Jean-Sébastien Annicotte; Stéphanie Miard; David Sarruf; Mitsuhiro Watanabe; Johan Auwerx
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.